CoChat

Neural network and deep-learning algorithms used in QSAR studies: merits and drawbacks

Open access
Ghasemi, Fahimeh, Mehridehnavi, Alireza, Pérez-Garrido, Alfonso, Pérez-Sánchez, Horacio · 2018 · Drug Discovery Today
Cited by 224

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

The past two decades are regarded as the golden age of using neural networks (NNs) in chemoinformatics. However, two major issues have arisen concerning their use: redundancy problems when dealing with small data sets, and the large number of compounds with thousands of descriptors, which gives rise to serious overfitting problems. Various NN algorithms, based on feature selection methods and learning algorithms, were devised to avoid these predicaments in drug discovery. Pruning the overfitting problem has emerged as another challenge in recent years, leading to the advent of deep-learning (DL) networks using innovative techniques. Here, we discuss the advantages and disadvantages of the proposed NN algorithms, especially the innovative DL techniques used in ligand-based virtual screening (VS).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.drudis.2018.06.016

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 224

Metadata

Authors
Ghasemi, F., Mehridehnavi, A., Pérez-Garrido, A., & Pérez-Sánchez, H.
Venue
Drug Discovery Today
Publisher
Elsevier BV
Published
2018-10
Volume
23
Issue
10
Pages
1784-1790
ISSN
1359-6446 (ISSN-L)
OpenAlex
W2809595040
Cited by
224
References
14
FWCI
18.29
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.